Safety Leadership, Worker Behaviour, Safety Performance, Integrative Model, Ghanaian Construction Industry Share and Cite: ...

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising costs ...

What would a Tesla be without controversy and split opinions? The Tesla Model Y’s midcycle refresh brought significant enough changes to earn it a spot in our 2026 SUV of the Year competition. The ...

Oct 14 (Reuters) - U.S. biotech firm Nabla Bio said on Tuesday it has signed a second major research partnership with Japanese drugmaker Takeda Pharmaceutical (4502.T), opens new tab, deepening their ...

Tesla has finally introduced the long-awaited, cheaper versions of its Model Y and Model 3 cars. The new cars, which the company unveiled in an X post on Tuesday, Oct. 7, are the brand’s most ...

New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior End-to-end support from experimental design to ...

For monoclonal antibodies (mAbs), traditional design space identification methods typically rely on expensive wet-lab experiments or in silico models that, for low-density data, need improvement. A ...

“High quality, large-scale, fit-for-purpose datasets” continues to be the tagline for artificial intelligence (AI) models aiming to achieve scalable drug discovery to novel targets. While troves of ...

UBC Okanagan researchers have developed a 3D bio-printed model that closely mimics the complexity of natural lung tissue, an innovation that could transform how scientists study lung disease and ...

A new kind of large language model, developed by researchers at the Allen Institute for AI (Ai2), makes it possible to control how training data is used even after a model has been built.